Gliptin treatment tied to higher risk of acute pancreatitis

September 27, 2016

(HealthDay)—Gliptin treatment is associated with increased acute pancreatitis risk, according to research published online Sept. 22 in Diabetes Care.

Ivan Tkac, M.D., Ph.D., from Pasteur University Hospital in Kosice, Slovakia, and Itamar Raz, M.D., from Hadassah Hebrew University Hospital in Jerusalem, combined data on the incidence of acute pancreatitis from three large randomized controlled trials designed to examine the and efficacy of add-on gliptin treatment. Data were included from SAVOR-TIMI 53 (saxagliptin), EXAMINE (alogliptin), and TECOS (sitagliptin) for 18,238 gliptin-treated patients and 18,157 placebo-treated patients.

The researchers found that gliptin-treated patients had significantly increased incidence of acute pancreatitis (odds ratio, 1.79; P = 0.013). There was a small difference in absolute risk (0.13 percent).

"Treatment with gliptins significantly increased the risk for in a combined analysis of three large controlled randomized trials," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Sitagliptin not linked to higher fracture risk in diabetes

More information: Full Text (subscription or payment may be required)

Related Stories

Sitagliptin not linked to higher fracture risk in diabetes

September 14, 2016
(HealthDay)—Patients with diabetes often have fractures, but sitagliptin is not associated with increased fracture risk, according to a study published online Sept. 8 in Diabetes, Obesity and Metabolism.

Saxagliptin not linked to increased fracture risk in T2DM

September 25, 2015
(HealthDay)—For patients with type 2 diabetes, treatment with saxagliptin is not associated with increased fracture risk, according to a study published online Sept. 10 in Diabetes Care.

Metformin linked to increased risk of acute dialysis in T2DM

August 23, 2016
(HealthDay)—For patients with type 2 diabetes, metformin is associated with about a 50 percent increase in the risk of acute dialysis compared to sulfonylureas, according to a study published online Aug. 18 in Diabetes, ...

Risk factors identified for acute pancreatitis that can disrupt leukemia treatment

April 25, 2016
Researchers have identified a rare genetic variation associated with a dramatically increased risk of severe acute pancreatitis in acute lymphoblastic leukemia (ALL) patients treated with the chemotherapy agent asparaginase. ...

Diabetes drug Sitagliptin shows no increased risk of heart events

June 9, 2015
A clinical trial of the glucose-control drug sitagliptin among patients with type 2 diabetes and established cardiovascular disease has found it did not raise the risk of major adverse cardiovascular events.

Early precut sphincterotomy ups primary cannulation rates

September 29, 2015
(HealthDay)—Early use of precut sphincterotomy does not increase the risk of pancreatitis but does increase rates of primary cannulation during endoscopic retrograde cholangiopancreatography (ERCP), according to research ...

Recommended for you

Taking the virus out of a mosquito's bite

December 12, 2018
They approach with the telltale sign—a high-pitched whine. It's a warning that you are a mosquito's next meal. But that mosquito might carry a virus, and now the virus is in you. Now, with the help of state-of-the-art technology, ...

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

Human antibody discovery could save lives from fungal killer

December 11, 2018
A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

December 11, 2018
Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue ...

Dialysis patients at risk of progressive brain injury

December 10, 2018
Kidney dialysis can cause short-term 'cerebral stunning' and may be associated with progressive brain injury in those who receive the treatment for many years. For many patients with kidney failure awaiting a kidney transplant ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.